XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.3

Debt - (Tables)

9 Months Ended

Sep. 30, 2024

Debt Instrument, Redemption [Line Items]

Summary of liability for sale of future royalties

​

​	​	​	​	​
​		Nine Months Ended September 30,		​
Liability for sale of future royalties- (current and noncurrent)	​	2024		​
Beginning balance as of December 31, 2023	​	$	1,814,097	​
Less: Non-cash royalty revenue payable to Royalty Pharma	​	​	(128,877)	​
Plus: Non-cash interest expense recognized	​	​	155,039	​
Plus: Cash received from Royalty Pharma	​	​	241,792	​
Ending balance	​	$	2,082,051	​
Effective interest rate as of September 30, 2024	​		9.9%	​

1.50% Convertible senior notes due 2026

Debt Instrument, Redemption [Line Items]

Summary of convertible notes

​

​	​	​	​	​	​	​	​
​		​	​	​	​	​	​
​	​	September 30, 2024		​	December 31, 2023		​
Principal	​	$	287,500	​	$	287,500	​
Less: Debt issuance costs	​		(2,394)	​		(3,287)	​
Net carrying amount	​	$	285,106	​	$	284,213	​

Summary of interest expense recognized related to the Convertible Notes

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30,

​

​

Nine Months Ended September 30,

​

​

2024

​

2023

2024

​

2023

​

Contractual interest expense

​

$

1,081

​

$

1,080

​

$

3,224

​

$

3,215

​

Amortization of debt issuance costs

​

300

​

​

294

​

​

891

​

​

872

​

Total

​

$

1,381

​

$

1,374

​

$

4,115

​

$

4,087

​

Effective interest rate

​

1.9

%

​

1.9

%

​

1.9

%

​

1.9

%

​

Blackstone Credit Agreement

Debt Instrument, Redemption [Line Items]

Schedule of credit agreement

​

​	​	​	​	​	​	​
​		September 30, 2024		​	December 31, 2023
Principal	​	$	—	​	$	300,000
Less: Debt issuance costs	​		—	​	​	—
Repayment of senior secured term loan	​	​	—	​	​	(300,000)
Net carrying amount	​	$	—	​	$	—

Summary of interest expense recognized related to debt

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Nine Months Ended

​

​

September 30,

​

September 30,

​

​

2024

​

2023

​

2024

​

2023

​

Contractual interest expense

$

—

​

$

9,554

​

$

—

​

$

28,087

​

Amortization of debt issuance costs

—

​

280

​

​

—

​

​

702

​

Total

$

—

​

$

9,834

​

$

—

​

$

28,789

​

Effective interest rate

​

—

%

​

13.1

%

​

—

%

​

13.1

%

X

- Definition

Tabular disclosure of activity related to the liability resulting from the sale of future royalties.

+ References

No definition available.

+ Details

Name:	ptct_LiabilityForSaleOfFutureRoyaltiesTableTextBlock
Namespace Prefix:	ptct_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of interest expense recognized related to convertible debt.

+ References

No definition available.

+ Details

Name:	ptct_ScheduleOfInterestExpenseRecognizedRelatedToConvertibleDebtTableTextBlock
Namespace Prefix:	ptct_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of interest expense recognized related to debt.

+ References

No definition available.

+ Details

Name:	ptct_SummaryOfInterestExpenseRecognizedRelatedToDebtTableTextBlock
Namespace Prefix:	ptct_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.

+ References

No definition available.

+ Details

Name:	us-gaap_ConvertibleDebtTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_DebtInstrumentRedemptionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_DebtInstrumentAxis=ptct_ConvertibleSeniorNotes1.5DueSeptember152026Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: